Furthermore, Kuperwasser et al. demonstrated that the co-transplantation of precancerous breast cells with genetically engineered CAFs (fibroblasts overexpressing HGF and/or TGF-β1) into the cleared mammary fat pads of immuno-deficient mice induced mammary tumors [20]. The gene discussed is TGFB1; the disease is breast cancer.